What are the treatment options for heavy menstrual bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Heavy Menstrual Bleeding

The most effective first-line treatment for heavy menstrual bleeding is the levonorgestrel-releasing intrauterine device (LNG-IUD), which reduces menstrual blood loss by 71-95% while providing contraception. 1

First-Line Treatment Options

  • Levonorgestrel-releasing IUD (LNG-IUD): Most effective first-line treatment, reducing menstrual blood loss by 71-95% 1, 2
  • NSAIDs for short-term treatment (5-7 days) during days of bleeding:
    • Ibuprofen: 400 mg every 4-6 hours as needed for dysmenorrhea 3
    • Naproxen and other NSAIDs have been shown to significantly reduce mean total menstrual blood loss 4, 2
  • Tranexamic acid: Non-hormonal option that reduces bleeding by 26-60%, more effective than NSAIDs and oral progestins 5, 6
    • Typical dosage: 3.9-4 g/day for 4-5 days starting from the first day of menstrual cycle 5
    • Contraindicated in women with active thromboembolic disease or history of thrombosis 2, 5

Second-Line Treatment Options

  • Cyclic oral progestins: Reduce bleeding by approximately 87%, though may result in irregular bleeding patterns 1
  • Combined hormonal contraceptives: Effective for reducing menstrual blood loss when hormonal options are appropriate 2
  • Antifibrinolytic agents (e.g., tranexamic acid): Reduce bleeding symptoms in patients with fibroids or other causes of heavy bleeding 4

Treatment Algorithm

  1. Initial assessment:

    • Evaluate severity of bleeding (bleeding that saturates a large pad or tampon hourly for ≥4 hours requires urgent evaluation) 1
    • Rule out pregnancy in reproductive-age women 1, 2
    • Check for signs of hemodynamic instability (tachycardia, hypotension) 1
    • Evaluate for underlying gynecological problems (STDs, uterine conditions like polyps or fibroids) 4, 2
  2. First-line treatment:

    • For women desiring contraception or long-term solution: LNG-IUD 1, 2
    • For short-term symptom management: NSAIDs for 5-7 days during bleeding 4, 2
    • For non-hormonal option: Tranexamic acid for 4-5 days starting from first day of cycle 5, 7
  3. If bleeding persists after first-line treatment:

    • Consider alternative medical treatments or combination therapy 4
    • For Cu-IUD users with heavy bleeding: NSAIDs for 5-7 days 4
    • For implant users with heavy bleeding: NSAIDs, hormonal treatment with low-dose COCs, or tranexamic acid 4
  4. For refractory cases:

    • Consider endometrial ablation techniques when medical treatment fails 1
    • Hysterectomy is a definitive treatment when other options have failed 1

Comparative Effectiveness

  • Tranexamic acid reduces menstrual blood loss by 54% compared to 20% reduction with mefenamic acid (an NSAID) 6
  • LNG-IUD is more effective than tranexamic acid for reducing menstrual blood loss 5
  • Tranexamic acid is significantly more effective than placebo, NSAIDs, and oral cyclical luteal phase progestins 5, 7

Special Considerations

  • Enhanced counseling about expected bleeding patterns improves treatment adherence 4
  • If bleeding remains unacceptable despite treatment, counsel on alternative methods or refer for surgical management 4
  • Up to 20% of women with heavy menstrual bleeding may have an underlying inherited bleeding disorder 2
  • Tranexamic acid significantly improves quality of life in women treated for heavy menstrual bleeding 5, 8

Common Pitfalls and Caveats

  • Avoid tranexamic acid in women with active thromboembolic disease or history of thrombosis 2, 5
  • NSAIDs should be used at the lowest effective dose for the shortest duration to minimize gastrointestinal side effects 3, 9
  • For Cu-IUD users, unscheduled spotting or light bleeding, as well as heavy bleeding, is common during the first 3-6 months and generally decreases with continued use 4
  • Hormone-free intervals are not recommended more than once per month for CHC users on extended or continuous regimens as contraceptive effectiveness might be reduced 4

References

Guideline

Management of Dizziness Due to Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Heavy Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tranexamic acid therapy for heavy menstrual bleeding.

Expert opinion on pharmacotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.